| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.68B | 84.41B | 82.11B | 83.86B | 80.14B | 84.92B |
| Gross Profit | 20.62B | 20.28B | 16.86B | 18.48B | 21.05B | 17.22B |
| EBITDA | 9.71B | 9.76B | 767.00M | 9.61B | 13.76B | 2.43B |
| Net Income | 4.87B | 5.01B | -7.09B | 2.34B | 6.75B | -2.80B |
Balance Sheet | ||||||
| Total Assets | 123.36B | 123.32B | 125.44B | 128.02B | 123.92B | 123.01B |
| Cash, Cash Equivalents and Short-Term Investments | 16.39B | 16.18B | 16.59B | 12.41B | 10.80B | 11.09B |
| Total Debt | 22.98B | 21.92B | 27.04B | 21.64B | 16.96B | 20.44B |
| Total Liabilities | 45.67B | 43.93B | 49.98B | 43.31B | 41.21B | 43.74B |
| Stockholders Equity | 76.64B | 78.29B | 74.39B | 80.49B | 78.85B | 75.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.06B | 2.84B | -1.89B | 1.50B | -1.74B |
| Operating Cash Flow | 0.00 | 12.01B | 6.87B | 773.00M | 6.57B | 7.83B |
| Investing Cash Flow | 0.00 | -5.71B | -3.96B | -2.62B | -1.65B | -7.42B |
| Financing Cash Flow | 0.00 | -6.88B | 1.26B | 3.28B | -5.65B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥289.18B | 22.91 | ― | 1.00% | -3.06% | 45.21% | |
74 Outperform | ¥111.27B | 7.99 | ― | 4.15% | 1.16% | 167.89% | |
70 Outperform | ¥55.03B | 8.46 | ― | 4.37% | -1.09% | ― | |
68 Neutral | ¥73.89B | 11.94 | ― | 3.74% | -0.68% | -9.93% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ¥66.81B | 34.78 | ― | 1.60% | 1.20% | ― |
Sakai Chemical Industry Co., Ltd. has resolved at its board meeting on December 23, 2025 to cancel 1,000,000 of its common treasury shares, equivalent to 5.88% of its issued shares prior to cancellation, under Article 178 of the Companies Act. The cancellation, which includes shares repurchased via ToSTNeT-3 and on the Tokyo Stock Exchange between May 15 and November 30, 2025, is scheduled for January 30, 2026 and will reduce the company’s total shares outstanding to 16,000,000 and leave 688,751 treasury shares, effectively tightening its share float and potentially enhancing capital efficiency and shareholder value.
The most recent analyst rating on (JP:4078) stock is a Buy with a Yen3099.00 price target. To see the full list of analyst forecasts on Sakai Chemical Industry Co., Ltd. stock, see the JP:4078 Stock Forecast page.
Sakai Chemical Industry Co., Ltd. has completed the acquisition of its own shares, purchasing a total of 914,000 shares at a cost of approximately 2.5 billion yen. This strategic move, resolved by the Board of Directors, aims to enhance shareholder value and involves plans to cancel all acquired treasury shares, potentially impacting the company’s stock market positioning and shareholder equity.
The most recent analyst rating on (JP:4078) stock is a Buy with a Yen3099.00 price target. To see the full list of analyst forecasts on Sakai Chemical Industry Co., Ltd. stock, see the JP:4078 Stock Forecast page.
Sakai Chemical Industry Co., Ltd. reported a decrease in net sales by 4.3% for the second quarter of 2025 compared to the same period in 2024. Despite the decline in sales, the company experienced a significant increase in operating profit by 25.1% and profit attributable to owners of the parent by 67.5%, indicating improved operational efficiency and profitability.
The most recent analyst rating on (JP:4078) stock is a Buy with a Yen3099.00 price target. To see the full list of analyst forecasts on Sakai Chemical Industry Co., Ltd. stock, see the JP:4078 Stock Forecast page.
Sakai Chemical Industry Co., Ltd. announced the results of its share acquisition program, which was resolved by the Board of Directors in May 2025. The company acquired 102,600 common shares for 291,919,100 yen between October 1 and October 31, 2025, through market purchases on the Tokyo Stock Exchange. This acquisition is part of a broader plan to acquire up to 1,000,000 shares, with the intent to cancel all treasury shares acquired, reflecting a strategic move to optimize capital structure and potentially enhance shareholder value.
The most recent analyst rating on (JP:4078) stock is a Buy with a Yen3099.00 price target. To see the full list of analyst forecasts on Sakai Chemical Industry Co., Ltd. stock, see the JP:4078 Stock Forecast page.